Candel Therapeutics (CADL)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from CADL's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Candel Therapeutics's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $125,000 | $125,000 | — | — | — |
| Net income | -$36M | -$19M | -$38M | -$55M | -$38M |
| Free cash flow | -$24M | -$33M | -$35M | -$27M | -$39M |
| EPS (diluted) | -$1.91 | -$0.65 | -$1.31 | -$1.74 | -$0.72 |
| Operating margin | -20580.8% | -27777.6% | — | — | — |
Superinvestors who own CADL
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | $210,296 | 0.0% | Q2 2026 |
Insider buying
Open-market purchases by Candel Therapeutics's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Feb 23, 2026 | Paul B Manning |
550,458 | $5.45 | $3M |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when CADL trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Candel Therapeutics insiders buying the stock?
1 open-market insider purchase of CADL in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Candel Therapeutics?
1 of the superinvestors Investingly tracks hold CADL in their latest 13F, including Cliff Asness.
Companies like Candel Therapeutics
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.